These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 37379152)

  • 21. Nicotinamide for prevention of nonmelanoma skin cancers: a change in practice?
    Nestor L; Clowry J; Molloy K; Connolly M; Salim A; Tobin AM
    Clin Exp Dermatol; 2017 Dec; 42(8):945-946. PubMed ID: 29044731
    [No Abstract]   [Full Text] [Related]  

  • 22. ACP Journal Club. In high-risk patients, oral nicotinamide reduced number of new nonmelanoma skin cancers during treatment.
    Hajdenberg J
    Ann Intern Med; 2016 Feb; 164(4):JC18. PubMed ID: 26882303
    [No Abstract]   [Full Text] [Related]  

  • 23. A phase II randomized controlled trial of nicotinamide for skin cancer chemoprevention in renal transplant recipients.
    Chen AC; Martin AJ; Dalziell RA; McKenzie CA; Lowe PM; Eris JM; Scolyer RA; Dhillon HM; Vardy JL; Bielski VA; Halliday GM; Damian DL
    Br J Dermatol; 2016 Nov; 175(5):1073-1075. PubMed ID: 27061568
    [No Abstract]   [Full Text] [Related]  

  • 24. Advances in the chemoprevention of non-melanoma skin cancer in high-risk organ transplant recipients.
    Lien MH; Fenske NA; Glass LF
    Semin Oncol; 2012 Apr; 39(2):134-8. PubMed ID: 22484184
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Authors' response to a reply to 'A phase II randomized controlled trial of nicotinamide for skin cancer chemoprevention in renal transplant recipients'.
    Damian DL; Martin AJ; Scolyer RA; Chen AC; Halliday GM
    Br J Dermatol; 2017 Feb; 176(2):552-553. PubMed ID: 27893156
    [No Abstract]   [Full Text] [Related]  

  • 26. Analysis of metformin, niacinamide, and niacin as skin cancer preventative medications in solid organ transplant recipients.
    Linkous C; Strat N; Shope C; Andrews L; Lee LW
    J Am Acad Dermatol; 2024 Feb; 90(2):436-438. PubMed ID: 37863201
    [No Abstract]   [Full Text] [Related]  

  • 27. Is the first-line systemic chemoprevention of nonmelanoma skin cancer nicotinamide or acitretin?
    Hoegler KM; Khachemoune A
    Int J Dermatol; 2021 Jun; 60(6):749-750. PubMed ID: 33565095
    [No Abstract]   [Full Text] [Related]  

  • 28. Nicotinamide for photoprotection and skin cancer chemoprevention: A review of efficacy and safety.
    Snaidr VA; Damian DL; Halliday GM
    Exp Dermatol; 2019 Feb; 28 Suppl 1():15-22. PubMed ID: 30698874
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prevention of non-melanoma skin cancers with nicotinamide in transplant recipients: a case-control study.
    Drago F; Ciccarese G; Cogorno L; Calvi C; Marsano LA; Parodi A
    Eur J Dermatol; 2017 Aug; 27(4):382-385. PubMed ID: 28468736
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Current Practices for Preventative Interventions for Nonmelanoma Skin Cancers Among Dermatologic Surgeons.
    Arzeno J; Leavitt E; Lonowski S; Kim J
    Dermatol Surg; 2021 Jul; 47(7):995-997. PubMed ID: 33587370
    [No Abstract]   [Full Text] [Related]  

  • 31. Chemoprevention of skin cancer.
    Horn MA; Gordon KB
    Cancer Treat Res; 2001; 106():255-82. PubMed ID: 11225006
    [No Abstract]   [Full Text] [Related]  

  • 32. Evaluation of the Use of Capecitabine for the Treatment and Prevention of Actinic Keratoses, Squamous Cell Carcinoma, and Basal Cell Carcinoma: A Systematic Review.
    Schauder DM; Kim J; Nijhawan RI
    JAMA Dermatol; 2020 Oct; 156(10):1117-1124. PubMed ID: 32639538
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Fibrohistiocytic tumors in a lung transplant patient taking oral capecitabine for nonmelanoma skin cancer chemoprevention.
    Konda S; Patel VA; O'Bryan KW; Ratner D
    Dermatol Surg; 2014 Jul; 40(7):807-10. PubMed ID: 24927001
    [No Abstract]   [Full Text] [Related]  

  • 34. Overview on non-melanoma skin cancers in solid organ transplant recipients.
    Forchetti G; Suppa M; Del Marmol V
    G Ital Dermatol Venereol; 2014 Aug; 149(4):383-7. PubMed ID: 25068224
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effectiveness of acitretin for skin cancer prevention in immunosuppressed and nonimmunosuppressed patients: A retrospective cohort study.
    Bhullar S; Christensen SR
    J Am Acad Dermatol; 2024 Apr; 90(4):821-822. PubMed ID: 38040337
    [No Abstract]   [Full Text] [Related]  

  • 36. Chemoprevention of Skin Carcinomas in High-Risk Transplant Recipients.
    Savoia P; Zavattaro E; Cremona O
    Curr Med Chem; 2018 Feb; 25(6):687-697. PubMed ID: 28971762
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prevention of non-melanoma skin cancer.
    Stratton SP
    Curr Oncol Rep; 2001 Jul; 3(4):295-300. PubMed ID: 11389812
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cyclo-oxygenase-2 inhibitors for chemoprevention of nonmelanoma skin cancer: is there a role for these agents?
    Liebman TN; Stein JA; Polsky D
    J Am Acad Dermatol; 2013 Jan; 68(1):173-6. PubMed ID: 23244374
    [No Abstract]   [Full Text] [Related]  

  • 39. Basic aspects of the pathogenesis and prevention of non-melanoma skin cancer in solid organ transplant recipients: a review.
    Perez HC; Benavides X; Perez JS; Pabon MA; Tschen J; Maradei-Anaya SJ; Lopez L; Lozano E
    Int J Dermatol; 2017 Apr; 56(4):370-378. PubMed ID: 27868187
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Counting keratinocyte carcinomas as a step to preventing them.
    Beatson M; Misitzis A; Weinstock MA
    J Am Acad Dermatol; 2019 Oct; 81(4):1030-1031. PubMed ID: 30935987
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.